OpenAI, FDA Discuss AI Integration in Drug Evaluations

The Icahn School of Medicine at Mount Sinai has become the first U.S. medical school to offer all medical and graduate students, along with select faculty and staff, access to OpenAI's secure ChatGPT Edu platform. This collaboration aims to enhance education and research by integrating advanced artificial intelligence tools, while ensuring full HIPAA compliance and strong safeguards for sensitive information. The initiative is designed to foster innovative learning, critical engagement with generative AI, and the development of ethical and practical skills for future healthcare professionals. Through this partnership, students gain access to the diverse data and resources of a major health system, improving their academic and research capabilities. Mount Sinai emphasizes responsible adoption of emerging technologies, balancing innovation with equity and data integrity. The rollout reflects a broader institutional effort to embed AI and machine learning across medical education and clinical practice.